Inventor · disambiguated record
Noa Shelach
Also filed as: SHELACH NOA
6 granted patents·7 pending applications·5 citations·filing 2002–2023
73Inventor score
Files withLUTRIS PHARMA LTD8KERYX BIOPHARMACEUTICALS INC2KERYX1LASTER MORRIS1MEMORIAL SLOAN KETTERING CANCER CENTER1
Top patents by PatentIndex Score
13 records- 0181US10927112B2BRaf inhibitors and use thereof for treatment of cutaneous reactionsLUTRIS PHARMA LTD·Filed 2019·Granted Feb 23, 2021·2 cites·24 claims
- 0280US11339163B2BRaf inhibitors and use thereof for treatment of cutaneous reactionsLUTRIS PHARMA LTD·Filed 2020·Granted May 24, 2022·1 cites·20 claims
- 0377US11197861B2Methods of screening BRaf inhibitors for treating cutaneous reactionsLUTRIS PHARMA LTD·Filed 2020·Granted Dec 14, 2021·1 cites·8 claims
- 0477US10632123B2Use of BRaf inhibitors for treating cutaneous reactionsLUTRIS PHARMA LTD·Filed 2018·Granted Apr 28, 2020·1 cites·12 claims
- 0566US2022274988A1Braf inhibitors and use thereof for treatment of cutaneous reactionsLUTRIS PHARMA LTD·Filed 2022·Application pending·0 cites
- 0661US2024122933A1Use of isoquinoline-1,5-diamines for wound healingLUTRIS PHARMA LTD·Filed 2023·Application pending·0 cites
- 0757US2023321106A1Use of topical braf inhibitor compositions for treatment of epidermal growth factor receptor downstream effectors - induced cutaneous reactionsLUTRIS PHARMA LTD·Filed 2023·Application pending·0 cites
- 0853US11458139B2Use of BRAF inhibitors for treating cutaneous reactions caused by treatment with a MEK inhibitorMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Oct 4, 2022·0 cites·11 claims
- 0952US11439648B2Use of topical BRAF inhibitor compositions for treatment of radiation dermatitisLUTRIS PHARMA LTD·Filed 2021·Granted Sep 13, 2022·0 cites·18 claims
- 1051US2008070862A1Methods using glycosaminoglycans for the treatment of nephropathyLASTER MORRIS·Filed 2007·Application pending·0 cites
- 1142US2003013680A1Methods using glycosaminoglycans for the treatment of nephropathyKERYX·Filed 2002·Application pending·0 cites
- 1241US2005209188A1Methods using glycosaminoglycans for the treatment of nephropathyKERYX BIOPHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1329US2003008844A1Use of sulodexide for the treatment of inflammatory bowel diseaseKERYX BIOPHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Noa Shelach files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →